Riskpilot← Back to searchSign inGet full accessSofmed AB
ABActiveOrg 5593308926Sorögatan 17 NbMedical specialists activities · NACE 8622Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
0% vs 2024
Equity ratio
79.9%
Financial strength
Net profit 2025
SEK -1K
+75% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK -1K | +75% |
| Total assets | SEK 700K | +0% |
| Equity | SEK 559K | +0% |
| Employees | 0 | — |
Legal name
Sofmed AB
Org number
5593308926
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 augusti 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk verksamhet i öppen vård ävensom idka förenlig verksamhet , Medicinsk utbildning, forskning , utveckling , företagsorganisation, bedriva handel med medicinska produkter , hälsokost, medicinska instrument och apparater, desifektanter lab. tester.
Address
Sorögatan 17 Nb
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −8 | — | −1 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −8 | 0 | −1 | −1 |
| Net financials | 685 | 1 | −3 | — |
| Profit before tax | 676 | 1 | −4 | −1 |
| Tax | −138 | −0 | −0 | −0 |
| Net profit | 538 | 1 | −4 | −1 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 701 | 565 | 701 | 700 |
| Equity | 563 | 565 | 561 | 559 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 138 | 0 | 140 | 141 |
| Total debt | 138 | — | 140 | 141 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20222025
Equity ratio
79.9%
This company
38.2%
Market median
+109% vs market
20222025
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20222025
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sofmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Iraklis Kokinidis | Chief Executive Officer | 0 companies |
| Felicia Jasmine Fransson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Ivanka Kokinidou | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Petra Maria Nilsson Andersson | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |